WHO/IARC Talc Carcinogenic Classification: Group 2A (2024)

IARC Talc Classification
WHO cancer research agency ruling
Classification Date	July 4, 2024
IARC Group	Group 2A — Probably carcinogenic
Prior Classification	Group 2B — Possibly carcinogenic
Evidence Basis	Limited human, sufficient animal, strong mechanistic
Products Affected	Baby powder, cosmetics, industrial talc
U.S. Regulatory Status	No mandatory testing (FDA rule withdrawn Nov 2025)
EU Regulatory Status	Ban on talc in cosmetics expected by 2027
Pending U.S. Lawsuits	67,115 (MDL 2738, March 2026)
Largest Verdict	$1.5 billion (Craft v. J&J, Dec 2025)

On July 4, 2024, the International Agency for Research on Cancer (IARC), the cancer research agency of the World Health Organization (WHO), reclassified talc from Group 2B ("possibly carcinogenic to humans") to Group 2A ("probably carcinogenic to humans") — the second-highest level of cancer certainty in the IARC classification system. The reclassification, published in IARC Monographs Volume 136, was based on a comprehensive review by a working group of 29 international experts who evaluated limited evidence for cancer in humans, sufficient evidence in experimental animals, and strong mechanistic evidence that talc exhibits key characteristics of carcinogens. The classification applies to all forms of talc, including talc that does not contain detectable asbestos fibers.

The reclassification arrived amid an unprecedented wave of litigation against talc manufacturers. As of March 2026, 67,115 lawsuits are pending in multidistrict litigation (MDL 2738) in the U.S. District Court for the District of New Jersey, with total filings exceeding 90,000. Johnson & Johnson, the largest defendant, had three bankruptcy attempts rejected by federal courts between 2021 and 2025, and jury verdicts in 2025 alone exceeded $2.5 billion.

The IARC decision has broad implications for public health, regulation, and litigation. The European Union plans to ban talc in all cosmetics by 2027, while the United States has no mandatory federal testing requirement for asbestos in cosmetic talc products after the FDA withdrew its proposed testing rule in November 2025.

Key Facts

Category	Detail
IARC Classification Date	July 4, 2024
Classification Level	Group 2A — "Probably carcinogenic to humans"
Prior Classification	Group 2B — "Possibly carcinogenic to humans"
Evidence Basis	Limited human evidence, sufficient animal evidence, strong mechanistic evidence
Expert Panel	29 international experts (IARC Monographs Volume 136)
Scope	All forms of talc, including talc without detectable asbestos
FDA Contamination Rate	9 of 52 cosmetic talc products (17%) contained asbestos (2019 testing)
Pending U.S. Lawsuits	67,115 in MDL 2738 (March 2026)
Largest Single-Plaintiff Verdict	$1.5 billion — Craft v. J&J, Baltimore, December 2025
J&J Bankruptcy Rejections	3 (LTL Management 2021, LTL 2023, Red River Talc 2025)
EU Regulatory Action	Ban on talc in cosmetics expected by 2027
U.S. Regulatory Status	No mandatory asbestos testing (FDA proposed rule withdrawn November 28, 2025)

What Is the IARC Group 2A Classification?

The International Agency for Research on Cancer (IARC) evaluates substances, mixtures, and exposures for their potential to cause cancer in humans. IARC's classification system uses four categories based on the strength and quality of available evidence:

Group	Classification	Evidence Standard	Examples
Group 1	"Carcinogenic to humans"	Sufficient evidence in humans	Asbestos, tobacco smoke, benzene
Group 2A	"Probably carcinogenic to humans"	Limited human evidence OR sufficient animal + strong mechanistic evidence	Talc (2024), glyphosate, red meat
Group 2B	"Possibly carcinogenic to humans"	Limited evidence in humans, less than sufficient in animals	Talc (prior classification, 1987–2024)
Group 3	"Not classifiable"	Inadequate evidence in humans and animals	Caffeine, cholesterol

The term "limited evidence" in IARC's framework does not mean absence of evidence. It indicates that epidemiological studies have identified an association between the substance and cancer, but that chance, bias, or confounding factors cannot be ruled out with sufficient confidence. When limited human evidence is combined with sufficient animal evidence and strong mechanistic evidence — as occurred with talc — the overall assessment rises to Group 2A.

For context, glyphosate — the active ingredient in Roundup herbicide — received the same Group 2A classification in 2015, which contributed to billions of dollars in litigation settlements against Bayer/Monsanto. The talc reclassification follows the same evidence framework and has had a comparable effect on talc litigation.

The 2024 Reclassification: From Group 2B to Group 2A

Prior Classification History

IARC first evaluated talc in 1987. At that time, the agency drew a distinction between two categories:

• Talc containing asbestiform fibers — classified as Group 1 ("carcinogenic to humans"), because asbestos itself is a known carcinogen
• Talc not containing asbestiform fibers — classified as Group 2B ("possibly carcinogenic") for perineal use, and Group 3 ("not classifiable") for inhaled talc

This separation allowed talc manufacturers to argue that their products — marketed as "asbestos-free" — fell into the lower-risk category. The distinction persisted for nearly four decades until the 2024 re-evaluation.

The IARC Monograph Volume 136 Decision

On July 4, 2024, the IARC Monographs Volume 136 working group — composed of 29 international experts from multiple countries and disciplines — published their findings after a multi-year review of all available evidence. The working group evaluated three streams of evidence:

1. Limited evidence for cancer in humans — Epidemiological studies showed an association between talc exposure and ovarian cancer, though confounding factors could not be fully excluded.
2. Sufficient evidence for cancer in experimental animals — Animal studies demonstrated that talc causes cancer in laboratory animals at relevant exposure levels.
3. Strong mechanistic evidence — Talc was found to exhibit key characteristics of carcinogens in human primary cells and experimental systems, including genotoxicity, oxidative stress, chronic inflammation, and immunosuppression. Talc met 8 of the 10 key characteristics of carcinogens defined in IARC's 2019 Preamble.

The 2024 evaluation superseded the previous separate classifications for "talc with asbestos" and "talc without asbestos." IARC now treats talc as a single substance for classification purposes, meaning the Group 2A designation applies to all forms of talc regardless of asbestos content. This represents a fundamental shift: even talc with no detectable asbestos contamination is now classified as probably carcinogenic.

The prior Group 1 classification for asbestos itself remains unchanged — asbestos remains a known human carcinogen at the highest certainty level. Talc contaminated with asbestos fibers therefore carries both classifications: the talc component is Group 2A, and the asbestos component is Group 1.

Why Does Talc Deposit Geology Matter?

The relationship between talc and asbestos is rooted in geology. Talc (Mg₃Si₄O₁₀(OH)₂) and asbestos minerals — including tremolite, anthophyllite, and chrysotile — share overlapping metamorphic formation conditions and frequently co-occur in the same geological deposits.

Geological Formation and Asbestos Contamination

A landmark 2004 study by the U.S. Geological Survey (Van Gosen et al.) established that the geological formation environment of a talc deposit directly predicts its asbestos contamination risk:

• Hydrothermal talcs (formed by replacement of dolostone): Consistently lack amphibole asbestos as accessory minerals
• Contact metamorphic talcs: Show a strong tendency to contain amphiboles, including asbestiform varieties
• Regional metamorphic talcs: Consistently contain amphiboles displaying a variety of compositions and habits, including asbestiform

This means the geological origin of a talc deposit is a reliable predictor of whether the resulting talc will contain asbestos. Many of the world's major talc-producing regions — including Gouverneur, New York; Val Chisone, Italy; and Vermont — are regional or contact metamorphic deposits that consistently contain tremolite and anthophyllite asbestos.

Why Complete Separation Is Impossible

Dr. Rodney Metcalf of the University of Nevada testified before the U.S. Congress that "talc and amphibole asbestos minerals can and certainly do co-exist at scales that cannot be mined in such a way as to exclude amphibole minerals." Johnson & Johnson's own internal documents acknowledged that "asbestos-form particles" could not be completely removed from talc ore, and that the company could not rely on the "clean mine" approach to assure the absence of asbestos.

Detection Method Limitations

The ability to detect asbestos in talc depends critically on the testing method used:

Method	Detection Limit	Tests for Chrysotile?	Notes
PLM (Polarized Light Microscopy)	~100 ppm (0.01%)	Yes	Quick and inexpensive; misses fine fibers
XRD (X-Ray Diffraction)	~5,000 ppm (0.5%)	No	Industry standard (J4-1 method); cannot distinguish fibrous from non-fibrous minerals
TEM (Transmission Electron Microscopy)	~0.000002%	Yes	Gold standard for sensitivity; expensive and time-consuming
SEM-EDS	Sub-micron resolution	Yes	High-resolution imaging with elemental analysis

The cosmetic talc industry's voluntary testing standard — the CTFA J4-1 method, established in 1976 — relied on XRD with a detection limit of 0.5% for amphibole asbestos and did not test for chrysotile asbestos at all. This meant that any amount of chrysotile was effectively permitted under the industry's own standard. In 2019, the FDA found chrysotile asbestos in Johnson's Baby Powder that had passed both the J4-1 method and J&J's proprietary TEM method.

Products Containing Talc

Baby Powder and Body Powder

Johnson's Baby Powder was the most widely used talc-based consumer product for decades. Gordon et al. (2014) demonstrated that a historic brand of cosmetic talcum powder contained asbestos, that application of the powder released inhalable asbestos fibers, and that lung and lymph node tissues of a user who developed mesothelioma contained anthophyllite and tremolite asbestos matching the talc product.

In October 2019, Johnson & Johnson recalled approximately 33,000 bottles of Baby Powder after FDA testing found chrysotile asbestos. The company discontinued talc-based Baby Powder in the United States and Canada in 2020 and globally in 2023, transitioning to cornstarch-based formulations.

Cosmetics

The FDA's 2019 survey of cosmetic talc products found asbestos in 9 of 52 products tested (17%), including products marketed to children:

• Claire's JoJo Siwa Makeup Set, Eye Shadows, Compact Powder, and Contour Palette — all contained tremolite asbestos
• Multiple Beauty Plus / City Color cosmetics — contained asbestos fibers

Claire's recalled the contaminated products, though the company initially disputed the FDA's findings.

Industrial Uses

According to the USGS Mineral Commodity Summary for 2025, talc produced in the United States was used primarily in:

• Plastics: 32%
• Ceramics: 21%
• Paint: 18%
• Paper: 9%
• Roofing: 8%
• Rubber: 6%

Global talc production in 2024 was approximately 6,900 thousand metric tons. Three companies operated five talc-producing mines in three U.S. states (Montana, Texas, and Vermont).

Exposure Routes

Exposure to asbestos in talc occurs through multiple pathways:

• Inhalation during application — Powder products release airborne fibers when applied to the body
• Peritoneal exposure through perineal use — Talcum powder applied to the perineal area can migrate through the reproductive tract to the peritoneal surface, creating a pathway to peritoneal mesothelioma
• Occupational inhalation — Cosmetologists, barbers, and healthcare workers face repeated exposure through daily product application

A 2023 study documented 166 individuals diagnosed with mesothelioma following cosmetic talc exposure. Of these, 73.5% had no other known asbestos exposure source — their only documented exposure was through consumer talc products. Peritoneal mesothelioma accounted for 31.3% of these cases, more than double the 10–15% rate in the general mesothelioma population, consistent with the perineal exposure pathway.

Regulatory Response

United States

FDA Proposed Rule and Withdrawal

In December 2024, the FDA proposed a rule under the Modernization of Cosmetics Regulation Act (MoCRA) of 2022 that would have required mandatory asbestos testing in all talc-containing cosmetic products. The rule would have required testing via polarized light microscopy (PLM) and transmission electron microscopy (TEM), and any detectable level of asbestos would have rendered a product adulterated under federal law.

On November 28, 2025, HHS Secretary Robert F. Kennedy Jr. officially withdrew the proposed rule, citing "Make America Healthy Again (MAHA) priorities" and a need to "reconsider best means of addressing the issues." This left a significant regulatory gap:

• No mandatory federal testing requirement exists for asbestos in cosmetic talc
• Testing remains entirely voluntary — cosmetic companies self-regulate
• The FDA's statutory obligation under MoCRA to establish testing standards still exists, but the agency has provided no timeline for a replacement rule
• The FDA's own 2019 testing data found asbestos in 17% of cosmetic talc products tested

EPA Asbestos Ban

The EPA finalized a comprehensive asbestos ban in 2024 under the Toxic Substances Control Act (TSCA). However, the Trump administration has signaled it may reconsider this ban, potentially weakening protections.

European Union

The European Chemicals Agency's (ECHA) Committee for Risk Assessment classified talc as a Category 1B carcinogen in September 2024, based on lung tumor studies and ovarian cancer evidence. Under EU law, this classification triggers an automatic prohibition in cosmetics. A ban on talc in all cosmetics in the EU is anticipated by 2027.

EU companies have already begun phasing out talc-containing products in anticipation of the ban. Any American brand selling in Europe will be required to reformulate talc-containing products, accelerating the global shift away from cosmetic talc.

United Kingdom

The UK Health and Safety Executive (HSE) is conducting a parallel assessment of talc under GB Classification, Labelling, and Packaging (CLP) regulations. As of January 2026, UK regulators concluded there was "not enough evidence to label talc a carcinogen" — diverging from the EU's approach.

Regulatory Comparison

Country/Region	Status	Key Actions
United States	No mandatory testing	FDA withdrew proposed rule Nov 2025; MoCRA obligation remains
European Union	Ban expected by 2027	ECHA RAC classified talc as Category 1B carcinogen (Sept 2024)
United Kingdom	Under review	HSE assessment ongoing; diverging from EU position
India	Minimal regulation	Major producer; 7 of 13 tested products contained asbestos
China	Largest producer	Limited public regulatory data available

Johnson & Johnson Litigation

Johnson & Johnson faces the largest mass tort in American history over its talc products. The litigation timeline spans decades of verdicts, settlements, and failed bankruptcy strategies.

Litigation Timeline

Year	Event
2018	$4.69 billion verdict for 22 women in St. Louis (ovarian cancer) — largest aggregate talc verdict
2019	J&J recalls 33,000 bottles after FDA finds chrysotile asbestos; discontinues in U.S./Canada 2020
2021	J&J creates LTL Management LLC — first "Texas Two-Step" bankruptcy attempt; dismissed by Third Circuit
2023	Second bankruptcy attempt dismissed by Judge Michael Kaplan; J&J ceases global talc Baby Powder sales
Sept 2024	Red River Talc LLC files Chapter 11, proposing $8 billion settlement fund
March 2025	Judge Christopher Lopez rejects third bankruptcy; J&J announces it will not appeal
March 2026	67,115 pending lawsuits in MDL 2738; first MDL bellwether trial expected in 2026

Key Talc Verdicts

Date	Case	Jurisdiction	Award	Cancer Type
Dec 2025	Craft v. J&J	Baltimore, MD	$1.5 billion	Peritoneal mesothelioma
Oct 2025	Moore v. J&J	Los Angeles, CA	$966 million	Mesothelioma
Dec 2025	Minnesota	Ramsey County, MN	$65.5 million	Mesothelioma
July 2025	Boston	Massachusetts	$42 million	Mesothelioma
June 2023	Lee v. J&J	Portland, OR	$260 million	Mesothelioma
July 2018	Ingham v. J&J (22 plaintiffs)	St. Louis, MO	$4.69 billion	Ovarian cancer
June 2025	Suffolk County	Massachusetts	$8 million	Mesothelioma

Total talc verdicts in 2025 exceeded $2.5 billion. Total 2024 mesothelioma talc verdicts exceeded $320 million. J&J has lost over $7 billion in jury verdicts across all talc litigation.

The Texas Two-Step Bankruptcy Strategy

Johnson & Johnson attempted three times to use a controversial legal maneuver known as the "Texas Two-Step" to resolve talc liabilities through bankruptcy. The strategy involves creating a new subsidiary, assigning all talc liabilities to it, and filing that subsidiary for bankruptcy — halting all litigation against the parent company.

All three attempts were rejected by federal courts:

1. 2021 — LTL Management LLC filed Chapter 11 in North Carolina. The Third Circuit dismissed the case, ruling LTL was not in genuine "financial distress" given J&J's $61.5 billion funding commitment.
2. 2023 — Second attempt also dismissed by U.S. Bankruptcy Judge Michael Kaplan.
3. 2024–2025 — Red River Talc LLC filed Chapter 11 with a proposed $8 billion settlement fund. Judge Christopher Lopez rejected the plan in March 2025. J&J announced on March 31, 2025 that it would not appeal and would "return to the tort system."

In January 2026, a federal judge allowed plaintiffs to add J&J affiliates as defendants in the MDL, potentially blocking future bankruptcy restructuring attempts.

Other Talc Defendants

Imerys Talc America

Imerys, once J&J's sole talc supplier, filed for Chapter 11 bankruptcy in 2019 after facing thousands of talc lawsuits. The company proposed a $1.45 billion trust fund to compensate claimants. In January 2024, Imerys and its former owner Cyprus Mines proposed a joint $862 million trust fund. As of early 2026, bankruptcy proceedings continue as insurance companies challenge the trust plan.

R.T. Vanderbilt / Vanderbilt Minerals

Vanderbilt Minerals mined industrial-grade tremolitic talc from the Gouverneur, New York, district — a regional metamorphic deposit consistently containing tremolite and anthophyllite asbestos. The company filed for bankruptcy in February 2026, citing $117.2 million in talc-related litigation costs from more than 1,400 lawsuits. A 2024 Connecticut jury awarded $15 million to the family of a mesothelioma victim, finding Vanderbilt showed "reckless indifference to others."

Colgate-Palmolive

Colgate-Palmolive faces 170+ active talc lawsuits related to its Cashmere Bouquet talcum powder product line, sold from the late 1800s through 1995. In 2015, a California jury found Colgate 95% responsible for a woman's mesothelioma and awarded $13 million. Evidence showed the talc was sourced from asbestos-contaminated mines in North Carolina, Montana, and Northern Italy.

Other Companies

• Whittaker, Clark & Daniels — Talc supplier; filed Chapter 11 in April 2023 after a $29.14 million mesothelioma verdict; cited 2,700+ lawsuits
• Revlon — Named in talc litigation; filed Chapter 11 in 2022 for broader financial reasons
• Avon Products — Named defendant in talc-asbestos litigation for cosmetic talc products

Legal Rights for Talc Exposure Victims

Individuals diagnosed with mesothelioma or other asbestos-related cancers after talc product exposure may have legal options for compensation. The 2023 Moline et al. study documented 166 mesothelioma cases linked to cosmetic talc exposure, with 73.5% having no other known asbestos exposure source — demonstrating that consumer product exposure alone can be sufficient to cause the disease.

Who May Qualify

• Cosmetic talc users diagnosed with mesothelioma (any type — pleural, peritoneal, or pericardial)
• No prior occupational asbestos exposure is required — consumer product use alone can support a claim
• Family members may file wrongful death claims

Compensation Pathways

• Civil lawsuits against product manufacturers (J&J, Colgate-Palmolive, etc.) and talc suppliers. Experienced mesothelioma attorneys can evaluate exposure history and identify all potential defendants.
• Asbestos trust funds — The Imerys and Cyprus Mines trusts are specifically relevant to talc claims. Claims can be filed simultaneously with civil lawsuits without one reducing the other. See the complete trust fund guide for filing details.

Statute of Limitations

The statute of limitations for mesothelioma claims runs from the date of diagnosis (not the date of exposure) in most states. Given mesothelioma's long latency period — median 32–34 years between first exposure and diagnosis — many cases filed today involve talc exposure from decades past. Filing deadlines vary by state, typically ranging from 1 to 3 years from diagnosis. See statute of limitations by state for specific deadlines.

For legal assistance, experienced mesothelioma attorneys can evaluate individual exposure histories and identify all potential sources of compensation. A free case evaluation can help determine eligibility.

Frequently Asked Questions

What does the WHO IARC Group 2A classification of talc mean?

The Group 2A classification means IARC's expert working group concluded that talc is "probably carcinogenic to humans" — the second-highest certainty level in the IARC classification system. This July 2024 decision upgraded talc from Group 2B ("possibly carcinogenic") and applies to all forms of talc, including talc that does not contain detectable asbestos fibers. The classification was based on limited evidence for cancer in humans, sufficient evidence in experimental animals, and strong mechanistic evidence that talc exhibits key characteristics of carcinogens.

Is talc the same as asbestos?

No. Talc and asbestos are distinct minerals, but they frequently co-occur in the same geological deposits because they form under similar metamorphic conditions. The USGS has documented that talc deposits formed through regional and contact metamorphism consistently contain amphibole asbestos minerals such as tremolite and anthophyllite. The IARC Group 2A classification applies to talc itself — separate from asbestos — meaning talc may be carcinogenic independent of asbestos contamination. Asbestos remains classified as Group 1 ("carcinogenic to humans"), the highest certainty level.

Can talc products cause mesothelioma without asbestos contamination?

IARC's 2024 Group 2A classification suggests this is probable — the evidence basis included mechanistic evidence that talc exhibits key characteristics of carcinogens independent of asbestos fiber content. However, most documented mesothelioma cases involving talc products also involve asbestos-contaminated talc. A 2023 study identified 166 mesothelioma patients with cosmetic talc exposure, with 73.5% having no other known asbestos exposure source, though the talc products they used may have contained asbestos fibers undetected by standard testing methods.

How many people have sued Johnson & Johnson over talc?

As of March 2026, 67,115 lawsuits are pending in the talc multidistrict litigation (MDL 2738) in the U.S. District Court for the District of New Jersey, with total filings exceeding 90,000. Johnson & Johnson's three bankruptcy attempts to resolve these claims through the "Texas Two-Step" strategy were all rejected by federal courts. The most recent rejection came in March 2025, after which J&J announced it would "return to the tort system."

Are talc products still on the market?

Yes. Johnson & Johnson discontinued talc-based baby powder globally in 2023, but other brands continue to sell talc-containing cosmetics in the United States. There is currently no mandatory federal testing requirement for asbestos in cosmetic talc products — the FDA withdrew its proposed testing rule in November 2025. The European Union plans to ban talc in all cosmetics by 2027.

What is the largest talc cancer verdict?

The largest single-plaintiff talc verdict is $1.5 billion, awarded in Craft v. Johnson & Johnson in Baltimore in December 2025, involving peritoneal mesothelioma. The jury awarded $59.8 million in compensatory damages and $1.5 billion in punitive damages. The largest aggregate talc verdict is $4.69 billion, awarded to 22 plaintiffs in St. Louis in July 2018 (later reduced to $2.12 billion on appeal).

Did the FDA ban talc?

No. The FDA proposed a rule in December 2024 requiring mandatory asbestos testing in cosmetic talc products under the Modernization of Cosmetics Regulation Act (MoCRA). HHS Secretary Robert F. Kennedy Jr. withdrew that rule on November 28, 2025. No mandatory federal talc testing standard currently exists, though the FDA's statutory obligation under MoCRA to establish standardized testing methods remains in effect. The FDA has stated it intends to propose a replacement rule but has provided no timeline.

See Also

• Asbestos_Fiber_Types_and_Potency
• Asbestos_Trust_Funds
• Mesothelioma_Lawyers
• Asbestos_Health_Effects
• Asbestos_in_Consumer_Products
• Pleural_Mesothelioma
• Peritoneal_Mesothelioma

Diagnosed with Mesothelioma After Talc Exposure?

If you or a loved one was diagnosed with mesothelioma and used cosmetic talc products, you may be entitled to compensation. The IARC Group 2A classification strengthens legal claims for talc exposure victims.

Free Case Evaluation →

📞 (866) 222-9990